Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  

作　　者：WU Xiao-long ZHUANG Hai-feng ZHAO Yan-na YU Xiao-ling DAI Tie-ying GAO Rui-lan 

机构地区：[1]Institute of Hematology Research,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou(310006),China

出　　处：《Chinese Journal of Integrative Medicine》2020年第5期324-329,共6页中国结合医学杂志（英文版）

基　　金：Supported by the National Natural Science Foundation of China(No.81774068);the Natural Science Foundation of Zhejiang Province(Youth Project,No.LQ19H290002)。

摘　　要：Graft-versus-host disease(GVHD)is the most common complication after allogeneic hematopoietic stem cell transplantation,and also an important factor affecting the survival and quality of life in patients after transplantation.Currently,immunosuppressive therapy is commonly used for GVHD,but the curative effect is not ideal.How to effectively prevent and treat GVHD is one of the difficulties to be solved urgently in the field of transplantation.In this paper,we summarize the latest progress in pathogenesis,prevention and treatment of GVHD with Chinese medicine(CM).We hope it will provide ideas and methods for exploring the mechanism and establishing a new comprehensive therapy for GVHD with CM.

关 键 词：Chinese MEDICINE HEMATOPOIETIC STEM cell TRANSPLANTATION GRAFT-VERSUS-HOST DISEASE 

分 类 号：R259[医药卫生—中西医结合]